-
Je něco špatně v tomto záznamu ?
Monitoring MCS patients on the intensive care unit: integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery
C. Vandenbriele, L. Baldetti, A. Beneduce, J. Belohlavek, C. Hassager, M. Pieri, A. Polzin, AM. Scandroglio, JE. Møller
Status neindexováno Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
- Publikační typ
- časopisecké články MeSH
Monitoring of the patient supported with a temporary mechanical circulatory support (tMCS) is crucial in achieving the best possible outcome. Monitoring is a continuous and labour-intensive process, as cardiogenic shock (CS) patients can rapidly deteriorate and may require new interventions within a short time period. Echocardiography and invasive haemodynamic monitoring form the cornerstone of successful tMCS support. During monitoring, it is particularly important to ensure that adequate end-organ perfusion is achieved and maintained. Here, we provide a comprehensive overview of best practices for monitoring the CS patient supported by a micro-axial flow pump, veno-arterial extracorporeal membrane oxygenation, and both devices simultaneously (ECMELLA approach). It is a complex process that encompasses device control, haemodynamic control and stabilization, monitoring of interventions, and assessment of end-organ function. The combined, continuous, and preferably protocol-based approach of echocardiography, evaluation of biomarkers, end-organ assessment, and haemodynamic parameters is crucial in assessing this critically ill CS patient population.
Department of Anaesthesia and Intensive Care IRCCS San Raffaele Scientific Institute Milan Italy
Department of Cardiology Odense University Hospital Odense Denmark
Department of Cardiology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
Department of Cardiovascular Diseases University Hospitals Leuven Herestraat 49 3000 Leuven Belgium
Department of Cardiovascular Sciences KU Leuven Herestraat 49 3000 Leuven Belgium
Groupe Cardio Vasculaire Interventionnel Clinique Pasteur Toulouse France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022321
- 003
- CZ-PrNML
- 005
- 20240116163013.0
- 007
- ta
- 008
- 240105s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/eurheartjsupp/suad130 $2 doi
- 035 __
- $a (PubMed)38093766
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Vandenbriele, Christophe $u Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium $u Department of Cardiovascular Diseases, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium $u Adult Intensive Care, Royal Brompton and Harefield Guy's & St.Thomas' NHS Foundation Trust, Sydney St, London SW3 6NP, UK
- 245 10
- $a Monitoring MCS patients on the intensive care unit: integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery / $c C. Vandenbriele, L. Baldetti, A. Beneduce, J. Belohlavek, C. Hassager, M. Pieri, A. Polzin, AM. Scandroglio, JE. Møller
- 520 9_
- $a Monitoring of the patient supported with a temporary mechanical circulatory support (tMCS) is crucial in achieving the best possible outcome. Monitoring is a continuous and labour-intensive process, as cardiogenic shock (CS) patients can rapidly deteriorate and may require new interventions within a short time period. Echocardiography and invasive haemodynamic monitoring form the cornerstone of successful tMCS support. During monitoring, it is particularly important to ensure that adequate end-organ perfusion is achieved and maintained. Here, we provide a comprehensive overview of best practices for monitoring the CS patient supported by a micro-axial flow pump, veno-arterial extracorporeal membrane oxygenation, and both devices simultaneously (ECMELLA approach). It is a complex process that encompasses device control, haemodynamic control and stabilization, monitoring of interventions, and assessment of end-organ function. The combined, continuous, and preferably protocol-based approach of echocardiography, evaluation of biomarkers, end-organ assessment, and haemodynamic parameters is crucial in assessing this critically ill CS patient population.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Baldetti, Luca $u Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Beneduce, Alessandro $u Groupe Cardio-Vasculaire Interventionnel, Clinique Pasteur, Toulouse, France
- 700 1_
- $a Belohlavek, Jan $u 2nd Department of Internal Medicine, Cardiovascular Medicine General Teaching Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Hassager, Christian $u Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- 700 1_
- $a Pieri, Marina $u Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Polzin, Amin $u Department of Cardiology, Pulmonology, and Vascular Medicine, University Hospital Düsseldorf, Medical Faculty of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany $u Department of Pulmonology, and Vascular Medicine, Cardiovascular Research Institute Düsseldorf (CARID), Düsseldorf, Germany
- 700 1_
- $a Scandroglio, Anna Mara $u Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 700 1_
- $a Møller, Jacob Eifer $u Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark $u Department of Cardiology, Odense University Hospital, Odense, Denmark
- 773 0_
- $w MED00005247 $t European heart journal supplements : journal of the European Society of Cardiology $x 1520-765X $g Roč. 25, Suppl I (2023), s. I24-I31
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38093766 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240105 $b ABA008
- 991 __
- $a 20240116163010 $b ABA008
- 999 __
- $a ok $b bmc $g 2036240 $s 1208766
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 25 $c Suppl I $d I24-I31 $e 20231213 $i 1520-765X $m European heart journal supplements $n Eur Heart J Suppl $x MED00005247
- LZP __
- $a Pubmed-20240105